top of page
Nelson Advisors >
European Healthcare Technology Investment Banking
Hilo Cuffless Blood Pressure Monitoring System: Technology, Clinical Validation, Regulatory Trajectory and Market Dynamics
Nelson Advisors
Aug 2
HealthTech M&A Multiples August 2026: Current Trends and Variables Driving Valuations
Nelson Advisors
Aug 2
The Frozen Digital Health IPO Window and the HealthTech Founder's Real Exit Map in 2026
Nelson Advisors
Aug 1
The AI Deflation Wave: Platform versus Wrapper Valuation Dynamics in Healthcare AI
Nelson Advisors
Aug 1
Cross Border Exits for HealthTech, Health AI, MedTech, Digital Health Founders: Why Your Most Likely Buyer Isn't in Your Country
Nelson Advisors
Aug 1
The €25M to €250M Sweet Spot: Why Europe's HealthTech Mid-Market Is Where Private Equity Returns Are Being Made in 2026
Nelson Advisors
Aug 1
Buy and Build in European HealthTech: A Playbook for Platform Selection, Bolt-On Sequencing and Multiple Arbitrage
Nelson Advisors
Aug 1
Five Emerging HealthTech Sub Sectors Private Equity Should Be Screening Now Before the Multiples Move
Nelson Advisors
Jul 31
The Strategic Transformation of Community Pharmacy within the NHS Neighbourhood Health Model
Nelson Advisors
Jul 31
Geographic Arbitrage in European HealthTech: Why the Next Platform Deal Might Be in the Nordics, DACH or the Netherlands, Not London
Nelson Advisors
Jul 31
Capitalising on HealthTech Regulation: Analysis of Thoma Bravo’s Acquisition of padoa
Nelson Advisors
Jul 30
Abbott’s Mission Led Artificial Intelligence Strategy
Nelson Advisors
Jul 30
This Week in European HealthTech, MedTech and Health AI: 31st July 2026
Nelson Advisors
Jul 30
Deconstructing the Smart Ring Landscape: A Technical and Strategic Evaluation of the Leep Ring Versus the Oura Ecosystem
Nelson Advisors
Jul 30
The Evolutionary Blueprint of Healthcare Artificial Intelligence: 10 Key Milestones
Nelson Advisors
Jul 29
Comparative Analysis of European Healthcare Technology Frameworks: Assessment, Reimbursement and Systemic Integration Pathways
Lloyd Price
Jul 29
Strategic Expansion and Technological Evolution in AI-Powered Cardiothoracic Clinical Research: An Analysis of Qureight’s $20 Million Series B Financing
Nelson Advisors
Jul 29
The First Single EPR for Primary and Secondary Care: Assessment of Nervecentre’s Expansion into Regional Cross Continuum EPR Platforms
Nelson Advisors
Jul 28
The Hardware Convergence in Artificial Intelligence: Architectural Transitions, Domain-Specific Sensing and Strategic Lessons from First Generation Ambient Devices
Nelson Advisors
Jul 28
Nelson Advisors: MedTech M&A Advisory and Lower to Mid Market Investment Banking
Nelson Advisors
Jul 28
bottom of page
